English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Kinetic methods were used to obtain regional estimates of benzodiazepine receptor concentration ( B max ) and equilibrium dissociation constant ( K d ) from high and low specific activity (SA) [ 11 C]flumazenil ([ 11 C] Ro 15-1788) positron emission tomography studies of five normal volunteers. The high and low SA data were simultaneously fit to linear and nonlinear three-compartment models, respectively. An additional inhibition study (pretreatment with 0.15 mg/kg of flumazenil) was performed on one of the volunteers, which resulted in an average gray matter K 1 / k 2  estimate of 0.68 ± 0.08 ml/ml (linear three-compartment model, nine brain regions). The free fraction of flumazenil in plasma ( f 1 ) was determined for each study (high SA f 1 : 0.50 ± 0.03; low SA f 1 : 0.48 ± 0.05). The free fraction in brain ( f 2 ) was calculated using the inhibition K 1 / k 2  ratio and each volunteer's mean f 1  value ( f 2  across volunteers = 0.72 ± 0.03 ml/ml). Three methods (Methods I–III) were examined. Method I determined five kinetic parameters simultaneously [ K 1 , k 2 , k 3  (= k on  f 2  B max ), k 4 , and k on  f 2 /SA] with no a priori constraints. An average k on  value of 0.030 ± 0.003 n M −1  min −1  was estimated for receptor-rich regions using Method I. In Methods II and III, the k on  f 2 /SA parameter was specifically constrained using the Method I value of k on  and the volunteer's values of f 2  and low SA (Ci/μmol). Four parameters were determined simultaneously using Method II. In Method III, K 1 / k 2  was fixed to the inhibition value and only three parameters were estimated. Method I provided the most variable results and convergence problems for regions with low receptor binding. Method II provided results that were less variable but very similar to the Method I results, without convergence problems. However, the K 1 / k 2  ratios obtained by Method II ranged from 1.07 in the occipital cortex to 0.61 in the thalamus. Fixing the K 1 / k 2  ratio in Method III provided a method that was physiologically consistent with the fixed value of f 2  and resulted in parameters with considerably lower variability. The average B max  values obtained using Method III were 100 ± 25 n M in the occipital cortex, 64 ±18 n M in the cerebellum, and 38 ± 5.5 n M in the thalamus; the average K d  was 8.9 ± 1.0 n M (five brain regions).

journal of cerebral blood flow and metabolism

Measurement of Benzodiazepine Receptor Number and Affinity in Humans Using Tracer Kinetic Modeling, Positron Emission Tomography, and [<sup>11</sup>C]Flumazenil

Measurement of Benzodiazepine Receptor Number and Affinity in Humans Using Tracer Kinetic Modeling, Positron Emission Tomography, and [11C]Flumazenil

Measurement of Benzodiazepine Receptor Number and Affinity in Humans Using Tracer Kinetic Modeling, Positron Emission Tomography, and [¹¹C]Flumazenil